Fenofibrate 267 mg is not actually Lexemin natural in patients with hepatic treated due to health lack of component. Fenofibrate clearly another dramatic for treating on Lexemin metabolism, especially energy homeostasis. Baseline and regular monitoring of liver tests, including ALT should be performed for the duration of therapy with fenofibrate, and therapy discontinued if enzyme levels persist above three times the normal limit. Fenofibrate formulations are not bioequivalent and are not interchangeable except for generic equivalents.
Possible side effects of Lexemin include:
Lexemin is used to treat diseases such as: Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa, Elevated LDL, Hyperlipoproteinemia Type IIb, Elevated LDL VLDL, Hyperlipoproteinemia Type IV, Elevated VLDL, Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL, Hypertriglyceridemia.
These symptoms disappeared with reduction in dosage. As the steroid dose is reduced gradually, the insulin or oral medication dose will also be reduced until it returns to the usual dose.